Expected Moves

Expected announcement of a necessary capital injection, highly likely to involve dilutive equity issuance or convertible debt to fund near-term operations.

Third-quarter operational update testing the company's ability to halt a 53% YoY revenue decline and normalize its distribution channels.

Anticipated board action to authorize a reverse stock split to regain listing compliance after prolonged trading below $1.00.